Background Although the pancreatic ductal adenocarcinoma (PDAC) presents high mortality
and metastatic potential, there is a lack of effective therapies and a low survival rate for this …

Introduction The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is
highly variable and there is a paucity of effective treatment options for patients with PDAC …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most complicated and fatally
pathogenic human malignancies. Therefore, there is an urgent need to improve our …

Background Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of
cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC …

Background Improved usage of the repertoires of pancreatic ductal adenocarcinoma
(PDAC) profiles is crucially needed to guide the development of predictive and prognostic …

Purpose Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Up
till now, the patient's prognosis remains poor which, among others, is due to the paucity of …

Background: Previous prognostic signatures of pancreatic ductal adenocarcinoma (PDAC)
are mainly constructed to predict the overall survival (OS), and their predictive accuracy …

Pancreatic cancer (PC) is associated with high mortality rates and poor prognoses.
Pancreatic adenocarcinoma is the most common type of PC, and almost all cases of …

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related
death and has an extremely poor prognosis. Thus, identifying new disease-associated …

Late diagnosis and systemic dissemination essentially contribute to the invariably poor
prognosis of pancreatic ductal adenocarcinoma (PDAC). Therefore, the development of …